A centenary to celebrate for the Jules Bordet Institute!
2019: centenary year of the Nobel Prize in Physiology/Medicine won by Prof Jules Bordet for his discoveries relating to immunity.
2019: centenary year of the Nobel Prize in Physiology/Medicine won by Prof Jules Bordet for his discoveries relating to immunity.
An innovative approach by the Jules Bordet Institute
Edito -- Du nouveau dans la prise en charge des jeunes patients -- Une nouvelle aventure 'patients et partenaires' -- Plus de 1.000 cas de Mobetron célébrés ....
Friday 22/11/2019 + Saturday 23/11/2019 (Parker Hotel Brussels - Diegem)
On 24 October 2019, the Jules Bordet Institute is holding its Patients' Associations Open Day!
Saturday 16/11/2019 (14-17 h) B19 Brussels : Av Van Bever, 19 - 1180 Brussels
What exactly do we mean by personalised breast cancer screening?
The Jules Bordet Institute supports the Movember campaign
All members of the Jules Bordet Institute and the care staff in particular need support, understanding and goodwill during this period of crisis.
The Jules Bordet Institute is participating in Nutrition Day 2020.
On the occasion of sarcoma awareness month, the Jules Bordet Institute is taking a look at the specific characteristics of these rare tumours that affect nearly 600 people a year in Belgium.
Lymphoma is a cancer of the immune system with around 1,250 new cases diagnosed every year in Belgium
Subsides 2022 - La radiothéranostique, les traitements de demain qui soignent déjà aujourd’hui (François Daubresse)
Today more than ever, the Hôpital Universitaire de Bruxelles (H.U.B) is supporting the fight against breast cancer
This acquisition will enrich the department's digital pathology platform
Progress in research is bringing great hope to women who want to have children
Il existe des facteurs de risque sur lesquels on PEUT AGIR.....
The MyPeBS Study : Advancing knowledge about breast cancer screening is essential
A programme to favour faster and more lasting rehabilitation for breast cancer patients
The risk of malnutrition is particularly high for cancer patients